HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recommended and actual lepirudin doses in patients with renal insufficiency.

AuthorsSarah B Saxer, Brian S Smith, Pritesh J Gandhi, Gary R Tataronis, Susan A Krikorian
JournalAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (Am J Health Syst Pharm) Vol. 60 Issue 24 Pg. 2588-93 (Dec 15 2003) ISSN: 1079-2082 [Print] England
PMID14735776 (Publication Type: Journal Article)
Chemical References
  • Anticoagulants
  • Hirudins
  • Recombinant Proteins
  • Heparin
  • lepirudin
Topics
  • Aged
  • Anticoagulants (administration & dosage, adverse effects, therapeutic use)
  • Dose-Response Relationship, Drug
  • Heparin (adverse effects)
  • Hirudins (administration & dosage, adverse effects, analogs & derivatives)
  • Humans
  • Recombinant Proteins (administration & dosage, adverse effects, therapeutic use)
  • Renal Insufficiency (complications)
  • Thrombocytopenia (chemically induced, complications, drug therapy)
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: